Forecast: Total Pharmaceutical Sales in Australia

The forecasted total pharmaceutical sales in Australia are projected to increase from USD 552.1 per capita in 2024 to USD 602.8 per capita by 2028. This represents a consistent rise in pharmaceutical expenditures per capita, averaging annual growth rates of 2.3% over the forecast period. The figures demonstrate a steady year-on-year growth, indicating positive momentum in the market. In percentage terms, the year-on-year growth rates are 2.3% for 2025, 2.2% for 2026, 2.2% for 2027, and 2.1% for 2028.

The total pharmaceutical sales per capita stood at USD 540.0 in 2023, marking a base year for the forecast growth. This indicates a solid upward trend over the forecast period, supported by increasing demand for pharmaceutical products and services.

Future trends to watch for include advancements in personalized medicine, the rise of biologics and biosimilars, and regulatory changes that could impact the pharmaceutical market dynamics. Additionally, the ongoing integration of digital health technologies and telemedicine services may further influence sales growth in the sector.